ASX IPO Crystal Commemorative

ASX IPO Crystal Commemorative

Crystal commemorative marking the initial public offering of Australian biotech firm Chimeric Therapeutics. The firm is developing a class of cell therapy drugs for the treatment of cancer.

(21ALJ210)

ASX IPO Crystal Commemorative (Back View)

Back view of custom crystal celebrating the initial public offering on the Australia Securities Exchange of Chimeric Therapeutics. (21ALJ210)